A detailed history of Omni 360 Wealth, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Omni 360 Wealth, Inc. holds 370 shares of LLY stock, worth $303,004. This represents 0.21% of its overall portfolio holdings.

Number of Shares
370
Previous 264 40.15%
Holding current value
$303,004
Previous $239 Million 37.15%
% of portfolio
0.21%
Previous 0.18%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$772.14 - $960.02 $81,846 - $101,762
106 Added 40.15%
370 $328 Million
Q2 2024

Jul 19, 2024

BUY
$724.87 - $909.04 $191,365 - $239,986
264 New
264 $239 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $778B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Omni 360 Wealth, Inc. Portfolio

Follow Omni 360 Wealth, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Omni 360 Wealth, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Omni 360 Wealth, Inc. with notifications on news.